ATE358722T1 - Kälte-adaptierte pferde influenza-viren - Google Patents

Kälte-adaptierte pferde influenza-viren

Info

Publication number
ATE358722T1
ATE358722T1 AT99941169T AT99941169T ATE358722T1 AT E358722 T1 ATE358722 T1 AT E358722T1 AT 99941169 T AT99941169 T AT 99941169T AT 99941169 T AT99941169 T AT 99941169T AT E358722 T1 ATE358722 T1 AT E358722T1
Authority
AT
Austria
Prior art keywords
virus
viruses
cold
influenza
equine influenza
Prior art date
Application number
AT99941169T
Other languages
German (de)
English (en)
Inventor
Patricia W Dowling
Julius S Youngner
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE358722T1 publication Critical patent/ATE358722T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99941169T 1998-08-13 1999-08-12 Kälte-adaptierte pferde influenza-viren ATE358722T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/133,921 US6177082B1 (en) 1998-08-13 1998-08-13 Cold-adapted equine influenza viruses

Publications (1)

Publication Number Publication Date
ATE358722T1 true ATE358722T1 (de) 2007-04-15

Family

ID=22460917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941169T ATE358722T1 (de) 1998-08-13 1999-08-12 Kälte-adaptierte pferde influenza-viren

Country Status (10)

Country Link
US (3) US6177082B1 (https=)
EP (2) EP1105497B1 (https=)
JP (3) JP4583602B2 (https=)
AT (1) ATE358722T1 (https=)
AU (1) AU760356B2 (https=)
CA (1) CA2339089C (https=)
DE (1) DE69935721T2 (https=)
DK (1) DK1105497T3 (https=)
ES (1) ES2286892T3 (https=)
WO (1) WO2000009702A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711389D0 (en) * 1997-06-04 1997-07-30 Univ Wales The Bacterial pheromones and uses therefor
US6482414B1 (en) 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US7029903B2 (en) * 2000-04-03 2006-04-18 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
ES2526191T3 (es) * 2002-04-26 2015-01-08 Medimmune, Llc Método para producir virus influenza B infeccioso en cultivo celular
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
US7262045B2 (en) * 2003-02-25 2007-08-28 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
EP1623015A4 (en) * 2003-05-15 2007-10-10 Univ Oklahoma State HA1 OF THE EQUINE-2 INFLUENZAVIRUS EXPRESSIVE DNA VACCINE
ATE469972T1 (de) * 2003-12-23 2010-06-15 Medimmune Llc Multiplasmid-system zur erzeugung des grippevirus
JP2008503938A (ja) * 2004-06-17 2008-02-07 ダブリュー ファイブ ネットワークス インコーポレイテッド 擬似雑音符号化通信システム
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CA2606429A1 (en) * 2005-04-21 2006-11-02 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20080241184A1 (en) * 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
PH12011502633A1 (en) * 2005-10-07 2012-11-12 Zoetis P Llc Vaccines and methods to treat canine influenza
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
ES2496315T3 (es) * 2005-10-19 2014-09-18 University Of Florida Research Foundation, Incorporated Materiales para el control de la enfermedad respiratoria en caninos
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
US7601502B2 (en) * 2005-11-01 2009-10-13 Intervet International B.V. Prime boost vaccine for the protection of equines against equine influenza
EP1779866A1 (en) 2005-11-01 2007-05-02 Intervet International BV Prime-boost vaccine for the protection of equines against viral infection
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CA2690196A1 (en) 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
EP2772266B1 (en) 2011-03-14 2019-07-31 Boehringer Ingelheim Animal Health USA Inc. Equine Rhinitis vaccine
KR101490292B1 (ko) 2012-04-16 2015-02-04 한국생명공학연구원 신규한 ｈ3ｎ8 말 인플루엔자 바이러스
JP2013099339A (ja) * 2013-01-04 2013-05-23 Wisconsin Alumni Research Foundation Ｈ３型ウマａ型インフルエンザウイルス
US10080792B2 (en) 2013-09-23 2018-09-25 Engen Bio, Inc. Influenza vaccine and therapy
CN104436157A (zh) 2013-09-23 2015-03-25 恩金生物有限公司 流感疫苗和治疗
CA2967532A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
MX2022007578A (es) 2019-12-18 2022-07-19 Intervet Int Bv Vacuna respiratoria oral.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518347A (en) 1965-05-28 1970-06-30 Inst Microbiologie Et D Hygien Vaccine for equine influenza
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
SE434346C (sv) * 1982-04-07 1985-10-28 Johann Haberl Cyklonavskiljare med filterenhet for avskiljning av stoff fran gas, varvid en veckad filterenhet er anordnad med en ringspalt mot avskiljarens centralror
DE3381376D1 (de) 1982-04-16 1990-05-03 Cornell Res Foundation Inc Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza.
US4683137A (en) 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4631191A (en) 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
US4920213A (en) 1985-06-20 1990-04-24 Biotechnology Research Partners, Ltd. Method and compositions useful in preventing equine influenza
US5149531A (en) 1990-06-27 1992-09-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Also Published As

Publication number Publication date
WO2000009702A1 (en) 2000-02-24
US6177082B1 (en) 2001-01-23
DK1105497T3 (da) 2007-07-30
EP1854886A3 (en) 2007-11-21
EP1854886A2 (en) 2007-11-14
US20030180322A1 (en) 2003-09-25
CA2339089A1 (en) 2000-02-24
DE69935721T2 (de) 2008-02-07
AU760356B2 (en) 2003-05-15
US6649169B2 (en) 2003-11-18
US6436408B1 (en) 2002-08-20
JP2012085657A (ja) 2012-05-10
JP2009297040A (ja) 2009-12-24
AU5487799A (en) 2000-03-06
JP4583602B2 (ja) 2010-11-17
DE69935721D1 (de) 2007-05-16
EP1105497A1 (en) 2001-06-13
JP5261338B2 (ja) 2013-08-14
ES2286892T3 (es) 2007-12-01
CA2339089C (en) 2009-06-02
JP2002522078A (ja) 2002-07-23
EP1105497B1 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
ATE358722T1 (de) Kälte-adaptierte pferde influenza-viren
WO2001060849A3 (en) Cold-adapted equine influenza viruses
TW200730188A (en) Vaccines and methods to treat canine influenza
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
RU2010116187A (ru) Способ получения вируса гриппа
AU4930001A (en) Cold-adapted equine influenza viruses
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
BR0015398A (pt) Vacinas para mycoplasma bovis e processos de uso
ATE375804T1 (de) Ribavirin-enthaltende vakzine
PT1187631E (pt) Prevencao de diabetes de tipo 1 e de outras doencas provocadas por enterovirus nao-polio
Dowling et al. Cold-adapted equine influenza viruses
WO2007135420A3 (en) Defective interfering virus
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
NO20025898D0 (no) Fremgangsmåte for å öke overlevelsesraten til akvatiske dyr eksponert for en akvatisk virus og sammensetninger til bruk for slikefremgangsmåter
DK1132466T3 (da) Kyllingeanæmivira med lav patogenicitet
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
Madkey et al. Journal of Contemporary Medicine and Dentistry
Thomson et al. Foot and Mouth Disease in Southern Africa: Re-evaluation of the approach to control
Klaring et al. Mathematical models for the spread and control of foot‐and‐mouth disease during the 1973 epidemic in Austria
Whitaker-Dowling et al. A new intranasal, modified-live virus vaccine for equine H3N8 influenza
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส
Hjulsager et al. Triple reassortant H3N2 with seasonal human H3, pandemic internal genes and N2 of swine origin circulates in Danish swine herds
Damrongwatanapokin Foot-and-mouth disease: potential mechanism for prevention.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1105497

Country of ref document: EP